Statistics for Ivermectin shows clinical benefits in mild to moderate COVID-19: A randomised controlled double-blind dose-response study in Lagos.
Total visits
views | |
---|---|
Ivermectin shows clinical benefits in mild to moderate COVID-19: A randomised controlled double-blind dose-response study in Lagos. | 0 |
Total visits per month
views | |
---|---|
March 2024 | 0 |
April 2024 | 0 |
May 2024 | 0 |
June 2024 | 0 |
July 2024 | 0 |
August 2024 | 0 |
September 2024 | 0 |
File Visits
views | |
---|---|
Abstract QJM.docx | 2 |